-
Start Preamble
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on February 16, 2005, Varian, Inc., Lake Forest, 25200 Commercentre Drive, Lake Forest, California 92630-8810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules II:
Drug Schedule Phencyclidine (7471) II 1-Piperidinocyclohexane-carbonitrile (8603) II Benzoylecgonine (9180) II The company plans to manufacture small quantities of the listed controlled substances for use in diagnostic products.
Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Start Printed Page 17475Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than (60 days from publication).
Start SignatureDated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 05-6796 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 04/06/2005
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 05-6796
- Pages:
- 17474-17475 (2 pages)
- PDF File:
- 05-6796.pdf